Tyson Steel
Internal Medicine · Rupert, IDNPI 1750709796
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 70 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 18.1% — the pattern of someone who eats at a lot of different presentations. Among internal medicine clinicians in ID with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 70 payments — averaging $19.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$245
- AstraZeneca$233
- Boehringer Ingelheim$122
- Novartis$116
- Novo Nordisk$84
- Exact Sciences$80
- plus $477 from 14 others
What the payments were for
- Food & beverage$1,356100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 9 | $245 |
| AstraZeneca | 8 | $233 |
| Boehringer Ingelheim | 7 | $122 |
| Novartis | 6 | $116 |
| Novo Nordisk | 6 | $84 |
| Exact Sciences | 5 | $80 |
| Amgen | 4 | $65 |
| Dexcom, Inc. | 3 | $53 |
| Bayer | 3 | $50 |
| Lilly USA, LLC | 3 | $39 |
| Johnson & Johnson(2 entities) | 3 | $38 |
| Pfizer | 3 | $37 |
| Astellas Pharma US Inc | 1 | $34 |
| Inspire Medical Systems, Inc. | 1 | $33 |
| Boston Scientific | 2 | $30 |
| E.r. Squibb & Sons, L.L.C. | 2 | $27 |
| Merck | 1 | $24 |
| UCB, Inc. | 1 | $21 |
| Corium, LLC | 1 | $13 |
| Esperion Therapeutics, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,356 in reported general payments places this provider in the 90th percentile of 289 internal medicine providers in Idaho.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 58 | $79,259 |
| EliquisApixaban | 76 | $52,463 |
| JardianceEmpagliflozin | 26 | $38,190 |
| RybelsusSemaglutide | 15 | $30,791 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 47 | $30,142 |
| XareltoRivaroxaban | 25 | $27,693 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 40 | $25,894 |
| OzempicSemaglutide | 23 | $25,487 |
| FarxigaDapagliflozin Propanediol | 31 | $22,772 |
| Spiriva HandihalerTiotropium Bromide | 22 | $16,027 |
| TrulicityDulaglutide | 14 | $15,430 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 32 | $14,974 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 11 | $12,753 |
| Tresiba Flextouch U-100Insulin Degludec | 19 | $11,808 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 18 | $11,624 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $39 | $94,68972 claims |
| Novo NordiskRybelsus, Ozempic | $84 | $56,27838 claims |
| PfizerEliquis | $37 | $52,46376 claims |
| AstraZenecaBreztri Aerosphere, Farxiga, Symbicort | $233 | $51,60084 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat | $122 | $46,84243 claims |
| Johnson & JohnsonXarelto | $38 | $27,69325 claims |
| NovartisEntresto | $116 | $9,33715 claims |
| Astellas Pharma US IncMyrbetriq | $34 | $5,96314 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 289 internal medicine providers in Idaho.
Other internal medicine in Rupert
- Nichole ShumwayRupert$639
- Sherwin D'souzaPocatello$543K
- Diana DumitrascuEagle$143K
- Huiling QiBoise$62K
- Aditya SinghPocatello$37K
- Carolyn BridgesBoise$27K
- Susan WachterIdaho Falls$22K
- Ahmed MahmoodIdaho Falls$21K
- Eric BensonPost Falls$19K
- Douglas AndersenPocatello$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.